StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) stock

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 6/30
$2.67+0.12 (+4.71%)

Close on Nov 17, 2026Market cap $92.82MP/E –Yield –

Anixa Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Anixa Biosciences's price to sales ratio was 245.1× on Aug 31, 2022, against 243.2× a year earlier. Over the last 5 years it ranged from 2.1× to 288.7×, with a median of 86.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Aug 31, 2022245.1×+70.8
2021Dec 31, 2021174.3×−15.8
2020May 29, 2020190.1×−76.7
2019Dec 31, 2019266.8×+199.8
2018Dec 31, 201867.0×−41.1
2017Dec 29, 2017108.1×−49.4
2016Dec 30, 2016157.5×+154.7
2015Dec 31, 20152.8×−3.8
2014Dec 31, 20146.6×−95.7
2013Dec 31, 2013102.3×+66.8
2012Dec 31, 201235.4×+16.1
2011Dec 30, 201119.3×−24.9
2010Dec 31, 201044.2×–

More Anixa Biosciences figures

See a number that looks wrong?